TERESA GRAKLANOFF: Open Payments
NPI 1265461479 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,154 in 50 payments from 9 companies in 2025. Trend: 2023 $970 · 2024 $2,465 · 2025 $1,154
Food & beverage: $1,088Education: $66
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $486 |
| Janssen Biotech, Inc. | 5 | $219 |
| Arcutis Biotherapeutics, Inc. | 2 | $153 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| Galderma Laboratories, L.P. | 3 | $52 |
| UCB, Inc. | 2 | $50 |
| Organon LLC | 2 | $20 |
| LEO Pharma Inc. | 1 | $17 |
Products named: TREMFYA, SKYRIZI, RINVOQ, DUPIXENT, Bimzelx, COSENTYX, BOTOX, VTAMA.
Industry payments across ID — which companies pay providers there.
